Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB26FWEYM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120 count). This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The product will be delivered to Park Ridge, Illinois, and represents one of numerous recent delivery orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion enterprise-wide acquisition strategy. The underlying IDC, valued at up to $499,999,999 with a completion date of December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across multiple therapeutic categories and product lines positions it as a critical supplier within the federal pharmaceutical supply chain supporting global military medical operations.
Quick answers
Who was awarded contract SPE2DB26FWEYM?
SPE2DB26FWEYM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FWEYM worth?
The government has obligated $4,170 on SPE2DB26FWEYM.
Is contract SPE2DB26FWEYM an order under another contract?
Yes. SPE2DB26FWEYM is a delivery order under SPE2DB25D9320, an indefinite delivery contract.
Was contract SPE2DB26FWEYM competed?
The extent of competition for SPE2DB26FWEYM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award